176 related articles for article (PubMed ID: 15652243)
21. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.
Song DK; Zhao J; Zhang LR
J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368
[TBL] [Abstract][Full Text] [Related]
22. Reference intervals for thiopurine S-methyltransferase activity in red blood cells using 6-thioguanine as substrate and rapid non-extraction liquid chromatography.
Ford LT; Cooper SC; Lewis MJ; Berg JD
Ann Clin Biochem; 2004 Jul; 41(Pt 4):303-8. PubMed ID: 15298742
[TBL] [Abstract][Full Text] [Related]
23. Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?
Sanderson J; Ansari A; Marinaki T; Duley J
Ann Clin Biochem; 2004 Jul; 41(Pt 4):294-302. PubMed ID: 15298741
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of genetic polymorphisms of thiopurine S-methyltransferase (TPMT) in Mexican pediatric patients with cancer].
Moreno-Guerrero SS; Ramírez-Pacheco A; Dorantes-Acosta EM; Medina-Sanson A
Rev Invest Clin; 2013; 65(2):156-64. PubMed ID: 23844534
[TBL] [Abstract][Full Text] [Related]
25. Segregation analysis of human red blood cell thiopurine methyltransferase activity.
Vuchetich JP; Weinshilboum RM; Price RA
Genet Epidemiol; 1995; 12(1):1-11. PubMed ID: 7713396
[TBL] [Abstract][Full Text] [Related]
26. Structural characteristics determine the cause of the low enzyme activity of two thiopurine S-methyltransferase allelic variants: a biophysical characterization of TPMT*2 and TPMT*5.
Wennerstrand P; Dametto P; Hennig J; Klingstedt T; Skoglund K; Appell ML; Mårtensson LG
Biochemistry; 2012 Jul; 51(30):5912-20. PubMed ID: 22747506
[TBL] [Abstract][Full Text] [Related]
27. The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia.
Tumer TB; Ulusoy G; Adali O; Sahin G; Gozdasoglu S; Arinç E
Am J Hematol; 2007 Oct; 82(10):906-10. PubMed ID: 17617792
[TBL] [Abstract][Full Text] [Related]
28. Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come.
Ford LT; Berg JD
J Clin Pathol; 2010 Apr; 63(4):288-95. PubMed ID: 20354201
[TBL] [Abstract][Full Text] [Related]
29. The effect of thiopurine drugs on DNA methylation in relation to TPMT expression.
Hogarth LA; Redfern CP; Teodoridis JM; Hall AG; Anderson H; Case MC; Coulthard SA
Biochem Pharmacol; 2008 Oct; 76(8):1024-35. PubMed ID: 18708030
[TBL] [Abstract][Full Text] [Related]
30. Characterization of a variable number tandem repeat region in the thiopurine S-methyltransferase gene promoter.
Spire-Vayron de la Moureyre C; Debuysère H; Fazio F; Sergent E; Bernard C; Sabbagh N; Marez D; Lo Guidice JM; D'halluin JC; Broly F
Pharmacogenetics; 1999 Apr; 9(2):189-98. PubMed ID: 10376766
[TBL] [Abstract][Full Text] [Related]
31. Tracing the origin of the most common thiopurine methyltransferase (TPMT) variants: preliminary data from the patterns of haplotypic association with two CA repeats.
Alves S; Rocha J; Amorim A; Prata MJ
Ann Hum Genet; 2004 Jul; 68(Pt 4):313-23. PubMed ID: 15225157
[TBL] [Abstract][Full Text] [Related]
32. Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia?
Fakhoury M; Andreu-Gallien J; Mahr A; Medard Y; Azougagh S; Vilmer E; Jacqz-Aigrain E
J Clin Pharm Ther; 2007 Dec; 32(6):633-9. PubMed ID: 18021342
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a novel sequence variant, TPMT*28, in the human thiopurine methyltransferase gene.
Appell ML; Wennerstrand P; Peterson C; Hertervig E; Mårtensson LG
Pharmacogenet Genomics; 2010 Nov; 20(11):700-7. PubMed ID: 20881512
[TBL] [Abstract][Full Text] [Related]
34. Human pharmacogenetics of methyl conjugation.
Weinshilboum RM
Fed Proc; 1984 May; 43(8):2303-7. PubMed ID: 6714437
[TBL] [Abstract][Full Text] [Related]
35. Thiopurine methyltransferase and 6-thioguanine nucleotide measurement: early experience of use in clinical practice.
Gearry RB; Barclay ML; Roberts RL; Harraway J; Zhang M; Pike LS; George PM; Florkowski CM
Intern Med J; 2005 Oct; 35(10):580-5. PubMed ID: 16207256
[TBL] [Abstract][Full Text] [Related]
36. Duplex pyrosequencing of the TPMT*3C and TPMT*6 alleles in Korean and Vietnamese populations.
Lee SS; Kim WY; Jang YJ; Shin JG
Clin Chim Acta; 2008 Dec; 398(1-2):82-5. PubMed ID: 18775689
[TBL] [Abstract][Full Text] [Related]
37. Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease.
Winter JW; Gaffney D; Shapiro D; Spooner RJ; Marinaki AM; Sanderson JD; Mills PR
Aliment Pharmacol Ther; 2007 May; 25(9):1069-77. PubMed ID: 17439508
[TBL] [Abstract][Full Text] [Related]
38. Thiopurine methyltransferase pharmacogenetics: alternative molecular diagnosis and preliminary data from Northern Portugal.
Alves S; Prata MJ; Ferreira F; Amorim A
Pharmacogenetics; 1999 Apr; 9(2):257-61. PubMed ID: 10376773
[TBL] [Abstract][Full Text] [Related]
39. Thiopurine S-methyltransferase genetic polymorphism in the Thai population.
Srimartpirom S; Tassaneeyakul W; Kukongviriyapan V; Tassaneeyakul W
Br J Clin Pharmacol; 2004 Jul; 58(1):66-70. PubMed ID: 15206995
[TBL] [Abstract][Full Text] [Related]
40. [Relationships between thiopurine methyltransferase gene polymorphisms and its enzymatic activity].
Ma XL; Wu MY; Hu YM; Zu P; Li ZG
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):456-9. PubMed ID: 17152495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]